SLC34A3 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL267024	1.00	1/20
SCHEMBL267025	1.00	1/20
SCHEMBL267842	0.80	1/20
SCHEMBL267843	0.80	1/20
SCHEMBL267856	0.80	1/20
SCHEMBL267857	0.80	1/20
SCHEMBL267924	0.79	1/20
SCHEMBL267925	0.79	1/20
SCHEMBL268319	0.78	1/20
SCHEMBL268320	0.78	1/20
SCHEMBL274252	0.78	1/20
SCHEMBL266512	0.76	1/20
SCHEMBL266513	0.76	1/20
SCHEMBL267960	0.76	1/20
SCHEMBL267961	0.76	1/20
SCHEMBL267826	0.75	1/20
SCHEMBL267827	0.75	1/20
SCHEMBL274075	0.75	1/20
SCHEMBL265763	0.73	1/20
SCHEMBL265764	0.73	1/20

Clinical trials — most relevant to SLC34A3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH	PHASE3	COMPLETED
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases	PHASE2/PHASE3	WITHDRAWN
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)	PHASE2	COMPLETED
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	PHASE1/PHASE2	COMPLETED
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®	PHASE1/PHASE2	COMPLETED
Effect of, OAT3, on the Renal Secretion of Cefotaxime	PHASE1	COMPLETED
Healthy Combine Study	PHASE1	COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters	EARLY_PHASE1	COMPLETED
Oxalate and Citrate in Humans - Response to Citrate	nan	RECRUITING
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals	nan	ENROLLING_BY_INVITATION
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy	nan	COMPLETED
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital	nan	UNKNOWN
Cardiovascular Effects of Empagliflozine	nan	UNKNOWN
Calcitonin for Treating X-linked Hypophosphatemia	nan	COMPLETED
Sodium Transport: Genetics and Hypertension	nan	COMPLETED
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS	nan	NOT_YET_RECRUITING
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs	nan	COMPLETED
Epidemiology of Gout in French Polynesia	nan	COMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts	nan	COMPLETED
Studying Phosphorus Metabolism	nan	COMPLETED
Secondary Sclerosing Cholangitis in Critically Ill Patients	nan	ACTIVE_NOT_RECRUITING
Gene Expression in Inflammatory Bowel Disease	nan	ENROLLING_BY_INVITATION
Bile Acid Effects in Fetal Arrhythmia Study	nan	UNKNOWN
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism	nan	NOT_YET_RECRUITING
The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia	nan	COMPLETED
Renal Transporters After Renal Transplantation	nan	UNKNOWN
Biological Collection of Kidney Cells	nan	UNKNOWN
Lithium Countertransport and Blood Pressure In CARDIA and TOMHS	nan	COMPLETED
Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome	nan	RECRUITING
Genetic Regulation of Surfactant Deficiency	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC34A3 binder may also engage these)

Protein	Name	Similarity
Q80SU6	—	1.000	Q80SU6 →
Q8K4R8	—	0.999	Q8K4R8 →
SLC34A1	Sodium-dependent phosphate transport protein 2A	0.994	landscape →
O97704	—	0.991	O97704 →
Q60825	—	0.986	Q60825 →
Q28620	—	0.985	Q28620 →
Q06496	—	0.982	Q06496 →
B5MEV3	—	0.973	B5MEV3 →
D2HSA6	—	0.972	D2HSA6 →
Q96Q91	—	0.969	Q96Q91 →
Q9GKY1	—	0.969	Q9GKY1 →
Q863Y7	—	0.969	Q863Y7 →
Q4FZU9	—	0.969	Q4FZU9 →
Q5E9R1	—	0.969	Q5E9R1 →
Q9NQ40	—	0.969	Q9NQ40 →
Q643R3	—	0.968	Q643R3 →
Q658P3	—	0.968	Q658P3 →
SOAT2	Sterol O-acyltransferase 2	0.968	landscape →
Q9D8F3	—	0.967	Q9D8F3 →
Q6P5W5	—	0.966	Q6P5W5 →
F1NXU8	—	0.966	F1NXU8 →
Q9CTG6	—	0.966	Q9CTG6 →
Q86U10	—	0.965	Q86U10 →
Q8K4V2	—	0.965	Q8K4V2 →
Q5RKL5	—	0.965	Q5RKL5 →
Q9DBP0	—	0.964	Q9DBP0 →
O88908	—	0.964	O88908 →
Q9BU23	—	0.964	Q9BU23 →
Q8VCZ9	—	0.963	Q8VCZ9 →
SLC5A2	Sodium/glucose cotransporter 2	0.963	landscape →